A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Clinical trial NCT07101328 · RECRUITING

Trial details

NCT number: NCT07101328
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin B-cell Lymphoma Lymphoma, Large B-Cell, Diffuse Lymphoma, Follicular Lymphoma, B-cell Marginal Zone Waldenstrom Macroglobulinemia Lymphoma, Mantle Cell

Start date: 2026-05-28
Primary completion: 2027-04-01
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.